Yoltech

Developer of gene editing and LNP delivery platforms for therapeutics

placeShanghai, Shanghai, China calendar_todayFounded 2021 language yoltx.com

Social engagement

Social engagement: 3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Decheng Capital.

Investor typeCountShare
Venture capital240%
Private equity120%
Other / undisclosed240%

Recent activity

30 Jun 2026
Event
HRSC 2026
26 Jun 2026
Event
2026 OHF International Hyperoxaluria Workshop
14 May 2026
Milestone
regulatory
Coming soon